Introduction: The State of Obesity in 2017

Medical Clinics of North America

Volumn 102, Issue 1, 2018, Pages 1-11

  Kushner, Robert F ^a   Kahan, Scott ^b,c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c Department of Health Policy and Management ^*  (United States)

Author keywords

Disease; Models of care; Morbidity; Obesity; Prevalence

Indexed keywords

AMFEBUTAMONE PLUS NALTREXONE; LIRAGLUTIDE; LORCASERIN; PHENTERMINE PLUS TOPIRAMATE;

BARIATRIC SURGERY; BEHAVIOR CHANGE; BODY MASS; CONTINUING EDUCATION; DIET THERAPY; DISABILITY-ADJUSTED LIFE YEAR; DISEASE CLASSIFICATION; DISEASE SEVERITY; GLOBAL DISEASE BURDEN; HEALTH CARE COST; HEALTH CARE NEED; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; KINESIOTHERAPY; MEDICAL PRACTICE; MEDICAL SOCIETY; MEDICAL SPECIALIST; MORBIDITY; MORTALITY; OBESITY; PATIENT ASSESSMENT; PATIENT CARE; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PRESCRIPTION; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROFESSIONAL COMPETENCE; PROGRAM EFFICACY; PUBLIC HEALTH SERVICE; REVIEW; RISK ASSESSMENT; RISK FACTOR; WEIGHT CONTROL; WEIGHT REDUCTION; WORLD HEALTH ORGANIZATION; DEVELOPED COUNTRY; DEVELOPING COUNTRY; FEMALE; FORECASTING; GLOBAL HEALTH; MALE; ORGANIZATION AND MANAGEMENT; PRIMARY HEALTH CARE;

BODY MASS INDEX; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; FEMALE; FORECASTING; GLOBAL HEALTH; HUMANS; MALE; OBESITY; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; PRIMARY HEALTH CARE;

EID: 85030750833     PISSN: 00257125     EISSN: 15579859     Source Type: Journal    
DOI: 10.1016/j.mcna.2017.08.003     Document Type: Review

References (51)

1. The Surgeon General's Call to Action to Prevent and Decrease Overweight and Obesity 2001. Available at: https://www.cdc.gov/nccdphp/dnpa/pdf/calltoaction.pdf. Accessed August 2, 2017.
2. Kontis, V., Mathers, C.D., Rehm, J., et al. Contribution of six risk factors to achieving the 25×25 non-communicable disease mortality reduction target: a modelling study. Lancet, 384, 2014, 427.
3. GBD 2015 Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med 377 (2017), 13–27.
4. McKinsey Global Institute. Overcoming obesity: an initial economic analysis, McKinsey and company. 2014. Available at: file:///C:/Users/Robert%20Kushner/Downloads/MGI_Overcoming_obesity_Full_report%20(1).pdf. Accessed July 30, 2017.
5. Weighing Down America: the health and economic impact of obesity. Available at: http://www.milkeninstitute.org/publications/view/833. Accessed August 2, 2017.
6. Singer, M., Bulled, N., Ostrach, B., et al. Syndemics and the biosocial conception of health. Lancet 389 (2017), 941–950.
7. NCD Risk Factor Collaboration. Trends in adult body-mass index in 200 countries from 1975 to 21014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet 387 (2016), 1377–1396.
8. Ogden, C.L., Carroll, M.D., Fryar, C.D., et al. Prevalence of obesity among adults and youth: United States, 2011-2014. NCHS Data Brief; No. 219. 2015, National Center for Health Statistics, Hyattsville (MD).
9. Flegal, K.M., Knuszon-Moran, D., Carroll, M.D., et al. Trends in obesity among adults in the United States, 2005-2014. J Am Med Assoc 315:20 (2016), 2284–2291.
10. Ogden, C.L., Carroll, M.D., Kit, B.K., et al. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 311:8 (2014), 806–814.
11. Prospective Studies Collaborative. Body-mass index and cause-specific mortality in 900,000 adults: collaborative analysis of 57 prospective studies. Lancet 373 (2009), 1083–1096.
12. Berrington de Gonzalez, A., Hartge, P., Cerhan, J.R., et al. Body-mass index and mortality among 1.6 million white adults. N Engl J Med 363 (2010), 2211–2221.
13. Nichols, G.A., Horberg, M., Koebnick, C., et al. Cardiometabolic risk factors among 1.3 million adults with overweight or obesity, but not diabetes, in 10 geographic diverse regions of the United States, 2012-2013. Prev Chronic Dis, 14, 2017, 160438.
14. The Global BMI Mortality Collaboration. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet 388 (2016), 776–786.
15. Aune, D., Sen, A., Prasad, M., et al. BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants. BMJ, 353, 2016, i2156.
16. Yu, E., Ley, S.H., Manson, J.E., et al. Weight history and all-cause and cause-specific mortality in three prospective cohort studies. Ann Intern Med 166:9 (2017), 613–620.
17. Petrick, J.L., Kelly, S.P., Liso, L.M., et al. Body weight trajectories and risk of oesophageal and gastric cardia adenocarcinomas: a pooled analysis of NIH-AARP and PLCO studies. Br J Cancer 116 (2017), 951–959.
18. Vistisen, D., Witte, D.R., Tabak, A.G., et al. Patterns of obesity development before diagnosis of type 2 diabetes: the Whitehall II Cohort Study. PLoS Med, 11(2), 2014, e1001602.
19. Wanigatunga, A.A., Sourdet, S.S., LaMonte, M.J., et al., for the Women's Health Initiative Investigators. Physical impairment and body weight history in postmenopausal women: the Women's Health Initiative. Public Health Nutr 19 (2016), 3169–3177.
20. Yuen MM, Kahan S, Kaplan LM, et al. Poster T-P-3166: a systematic review and evaluation of current evidence reveals 195 obesity-associated disorders. The Obesity Society. New Orleans, LA, October 31 - November 4, 2016.
21. Bray, G.A., Kim, K.K., Wilding, J.P.H., Obesity: a chronic relapsing progressive disease process. A Position Statement of the World Obesity Federation. Obes Rev 18 (2017), 715–723.
22. Ligibel, J.A., Alfano, C.M., Courneya, K.S., et al. American Society of Clinical Oncology Position Statement on Obesity and Cancer. J Clin Oncol 32:31 (2014), 3568–3574.
23. Lauby-Secretan, B., Scocdianti, C., Loomis, D., et al., for the International Agency for Research on Cancer Handbook Working Group. Body fatness and cancer–viewpoint of the IARC Working Group. N Engl J Med 375 (2016), 794–798.
24. Kygiou, M., Kalliala, I., Markozannes, G., et al. Adiposity and cancer at major anatomical sites: umbrella review of the literature. BMJ, 356, 2017, 477.
25. Acosta, A., Street, S., Kroh, M.D., et al. White paper AGA: POWER–practice guide on obesity and weight management, education, and resources. Clin Gastroenterol Hepatol 15:5 (2017), 631–649.
26. Sullivan, S., Edmundowicz, S.A., Thompson, C.C., Endoscopic bariatric and metabolic therapies: new and emerging technologies. Gastroenterology 152 (2017), 1791–1801.
27. Jensen, M.D., Ryan, D.H., Apovian, C.M. American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Obesity Society. 2013 AHA/ACC/TOS guidelines for the management of overweight and obesity is adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and The Obesity Society. Circulation 129:25 Suppl 2 (2014), S102–S138.
28. Garvey, W.T., Mechanick, J.I., Brett, E.M., et al. American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract 22:7 (2016), 842–884.
29. Obesity Algorithm: Clinical Guidelines for Obesity Treatment. Obesity Medical Association. Available at: https://obesitymedicine.org/obesity-algorithm/. Accessed September 21, 2017.
30. Apovian, C.M., Aronne, L.J., Bessesen, D.H., et al. Pharmacological management of obesity: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 100:2 (2015), 342–362.
31. Daniel, S., Soleymani, T., Garvey, W.T., A complications-based clinical staging of obesity to guide treatment modality and intensity. Curr Opin Endocrinol Diabetes Obes 20 (2013), 377–388.
32. Mechanick, J.I., Hurley, D.L., Garvey, W., Adiposity-based chronic disease as a new diagnostic term: the American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement. Endocr Pract 23:3 (2017), 372–378.
33. Sharma, A.M., Kushner, R.F., A proposed clinical staging system for obesity. Int J Obes (Lond) 33 (2009), 289–295.
34. Kuk, J.L., Ardern, C.I., Church, T.S., et al. Edmonton obesity staging system: association with weight history and mortality risk. Appl Physiol Nutr Metab 36 (2011), 570–576.
35. Padwal, R.S., Pajewski, N.M., Allison, D.B., et al. Using the Edmonton Obesity Staging System to predict mortality in a population-representative cohort of people with overweight and obesity. CMAJ 183:14 (2011), E1059–E1066.
36. Klabuncde, C.N., Clauser, S.B., Liu, B., et al. Organization of primary care practice for providing energy balance care. Am J Health Promot 28:3 (2014), e67–e80.
37. Steeves, J.A., Liu, B., Willis, G., et al. Physicians’ personal beliefs about weight-related care and their associations with care delivery: the U.S. National Survey of Energy Balance Related Care among Primary Care Physicians. Obes Res Clin Pract 9 (2015), 243–255.
38. Petrin, C., Kahan, S., Turner, M., et al. Current attitudes and practices of obesity counselling by health care providers. Obes Res Pract 11:3 (2017), 352–359.
39. Talwalker, A., McCarty, F., Characteristics of physician office visits for obesity by adults aged 20 and over: United States, 2012. NCHS Data Brief; No. 237. 2016, National Center for Health Statistics, Hyattsville (MD).
40. Asselin, J., Osuniana, A.M., Ogunieya, A.A., et al. Missing an opportunity: the embedded nature of weight management in primary care. Clin Obes 5 (2015), 325–332.
41. NORC and ASMBS. New insights into Americans’ perceptions and misperceptions of obesity treatments, and the struggles many face. Available at: http://www.norc.org/PDFs/ASMBS%20Obesity/Issue%20Brief%20B_ASMBS%20NORC%20Obesity%20Poll.pdf. Accessed August 2, 2017.
42. Igel, L., Kumar, R.B., Sanders, K.H., et al. Practical use of pharmacotherapy for obesity. Gastroenterology 152 (2017), 1765–1779.
43. Samaranayake, N.R., Ong, K.L., Leung, R.Y.H., et al. Management of obesity in the National Health and Nutrition Examination Survey (NHANES), 2007-2008. Ann Epidemiol 22:5 (2012), 349–353.
44. Zhang, S., Manne, S., Lin, J., et al. Characteristics of patients potentially eligible for pharmacotherapy for weight loss in primary car practice in the United States. Obes Sci Pract 2:2 (2016), 104–114.
45. Bodenheimer, T., Wagner, E.H., Grumbach, K., Improving primary care for patients with chronic illness. JAMA 288:14 (2002), 1775–1779.
46. Dietz, W.H., Solomon, L.S., Pronk, N., et al. An integrated framework for the prevention and treatment of obesity and its related chronic diseases. Health Aff 34:9 (2015), 1456–1463.
47. Deitz WH, Belay B, Bradley D, et al. A model framework that integrates community and clinical systems for the prevention and management of obesity and other chronic diseases. Washington, DC: National Academy of Medicine. Available at: https://nam.edu/wp-content/uploads/2017/01/A-Model-Frame-work-that-integrates-community-and-clinical-systems-for-the-prevention-and-management-of-obesity-and-other-chronic-diseases.pdf. Accessed July 30, 2017.
48. Campbell-Scherer, D.L., Asselin, J., Osunlana, A.M., et al. Implementation and evaluation of the 5As framework of obesity management in primary care: design of the 5As Team (5AsT) randomized control trial. Implementation Sci, 9, 2014, 78.
49. Ogunleye, A.A., Osunlana, A., Asselin, J., et al. The 5As team intervention: bridging the knowledge gap in obesity management among primary are practitioners. BMC Res Notes, 8, 2015, 810.
50. Milani, R.V., Lavie, C.J., Health Care 2020: reengineering health care delivery to combat chronic disease. Am J Med 128:4 (2015), 337–343.
51. Kushner, R.F., Brittan, D., Cleek, J., et al. The American Board of Obesity Medicine: five year report. Obesity 25:6 (2017), 982–983.